| Bevacizumab plus radiotherapy–temozolomide for newly diagnosed glioblastoma OL Chinot, W Wick, W Mason, R Henriksson, F Saran, R Nishikawa, ... New England Journal of Medicine 370 (8), 709-722, 2014 | 2677 | 2014 |
| Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial M Weller, N Butowski, DD Tran, LD Recht, M Lim, H Hirte, L Ashby, ... The Lancet Oncology 18 (10), 1373-1385, 2017 | 967 | 2017 |
| Predicting age of ovarian failure after radiation to a field that includes the ovaries WHB Wallace, AB Thomson, F Saran, TW Kelsey International Journal of Radiation Oncology* Biology* Physics 62 (3), 738-744, 2005 | 773 | 2005 |
| SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal … G Calaminus, R Kortmann, J Worch, JC Nicholson, C Alapetite, ML Garrè, ... Neuro-oncology 15 (6), 788-796, 2013 | 343 | 2013 |
| Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide: retrospective analysis of … T Sandmann, R Bourgon, J Garcia, C Li, T Cloughesy, OL Chinot, W Wick, ... Journal of clinical oncology 33 (25), 2735, 2015 | 322 | 2015 |
| Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma M Brada, S Stenning, R Gabe, LC Thompson, D Levy, R Rampling, ... J Clin Oncol 28 (30), 4601-4608, 2010 | 288 | 2010 |
| Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force J Treleaven, A Gennery, J Marsh, D Norfolk, L Page, A Parker, F Saran, ... British journal of haematology 152 (1), 35-51, 2011 | 274 | 2011 |
| UK consensus on normal tissue dose constraints for stereotactic radiotherapy GG Hanna, L Murray, R Patel, S Jain, KL Aitken, KN Franks, N Van As, ... Clinical Oncology 30 (1), 5-14, 2018 | 248 | 2018 |
| Radiotherapy of localised intracranial germinoma: time to sever historical ties? SJ Rogers, MA Mosleh-Shirazi, FH Saran The lancet oncology 6 (7), 509-519, 2005 | 228 | 2005 |
| Radiotherapy in the treatment of benign meningioma of the skull base C Nutting, M Brada, L Brazil, A Sibtain, F Saran, C Westbury, A Moore, ... Journal of neurosurgery 90 (5), 823-827, 1999 | 202 | 1999 |
| Outcome of patients with intracranial non-germinomatous germ cell tumors—lessons from the SIOP-CNS-GCT-96 trial G Calaminus, D Frappaz, RD Kortmann, B Krefeld, F Saran, T Pietsch, ... Neuro-oncology 19 (12), 1661-1672, 2017 | 186 | 2017 |
| A comparison of clinical target volumes determined by CT and MRI for the radiotherapy planning of base of skull meningiomas VS Khoo, EJ Adams, F Saran, JL Bedford, JR Perks, AP Warrington, ... International Journal of Radiation Oncology* Biology* Physics 46 (5), 1309-1317, 2000 | 167 | 2000 |
| Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis—an EORTC STBSG and ROG study (EORTC 62991–22998) RB Keus, RA Nout, JY Blay, JM De Jong, I Hennig, F Saran, JT Hartmann, ... Annals of Oncology 24 (10), 2672-2676, 2013 | 163 | 2013 |
| Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas G Minniti, F Saran, D Traish, R Soomal, S Sardell, A Gonsalves, S Ashley, ... Radiotherapy and oncology 82 (1), 90-95, 2007 | 162 | 2007 |
| Feasibility of Dosimetry-Based High-Dose 131I-Meta-Iodobenzylguanidine with Topotecan as a Radiosensitizer in Children with Metastatic Neuroblastoma MN Gaze, YC Chang, GD Flux, RJ Mairs, FH Saran, ST Meller Cancer biotherapy & radiopharmaceuticals 20 (2), 195-199, 2005 | 162 | 2005 |
| Health-related quality of life in a randomized phase III study of bevacizumab, temozolomide, and radiotherapy in newly diagnosed glioblastoma MJB Taphoorn, R Henriksson, A Bottomley, T Cloughesy, W Wick, ... Journal of Clinical Oncology 33 (19), 2166-2175, 2015 | 136 | 2015 |
| Medulloblastoma F Bartlett, R Kortmann, F Saran Clinical oncology 25 (1), 36-45, 2013 | 134 | 2013 |
| Hypofractionation vs conventional radiation therapy for newly diagnosed diffuse intrinsic pontine glioma: a matched-cohort analysis GO Janssens, MH Jansen, SJ Lauwers, PJ Nowak, FR Oldenburger, ... International Journal of Radiation Oncology* Biology* Physics 85 (2), 315-320, 2013 | 131 | 2013 |
| Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study BL Pizer, CL Weston, KJ Robinson, DW Ellison, J Ironside, F Saran, ... European journal of cancer 42 (8), 1120-1128, 2006 | 124 | 2006 |
| Phase II, open-label, randomized, multicenter trial (HERBY) of bevacizumab in pediatric patients with newly diagnosed high-grade glioma J Grill, M Massimino, E Bouffet, AA Azizi, G McCowage, A Cañete, ... Journal of Clinical Oncology, 2018 | 121 | 2018 |
